Descovy reaches protective levels in rectal tissue after about 7 days of daily use. For people taking it as part of HIV treatment (not prevention), viral load typically drops to undetectable levels within 8 to 24 weeks. The timeline depends on whether you’re using Descovy for PrEP or as a component of an HIV treatment regimen, and the type of exposure you’re protecting against.
Timeline for PrEP Protection
Most guidance for Descovy as PrEP follows the same principle established with its predecessor, Truvada: take it daily for at least 7 days before you can consider yourself protected through receptive anal sex. After seven consecutive days of dosing, the active drug builds up to effective concentrations in rectal tissue. This is sometimes called the “7-day loading period.”
The reason for this waiting period comes down to how the drug accumulates inside cells. Descovy contains tenofovir alafenamide (TAF), a prodrug that stays stable in your bloodstream and then gets converted into its active form inside cells. That active form, tenofovir diphosphate, needs to reach a high enough concentration in the tissues where HIV would try to establish infection. Building that concentration takes repeated daily doses.
One important limitation: Descovy for PrEP is only FDA-approved for people at risk through receptive anal sex. It is not approved for people assigned female at birth who are at risk from receptive vaginal sex, because its effectiveness for that route of exposure has not been studied. If vaginal sex is your primary risk factor, Truvada or injectable PrEP (cabotegravir) are the current options.
How Descovy Works Differently Than Truvada
Descovy and Truvada both deliver tenofovir into cells, but they get there differently. Truvada uses an older form called TDF, which breaks down quickly in your blood. The resulting tenofovir then has to make its way into cells on its own. Descovy uses TAF, which remains intact in the bloodstream longer and gets pulled inside cells before converting to its active form. The result is higher drug concentrations inside cells and lower levels circulating in your blood.
Those higher intracellular levels translate to strong antiviral activity. In a 10-day study of people with HIV, a 25 mg dose of TAF reduced viral levels about three times more than the standard 300 mg dose of TDF. The lower blood levels also mean less drug reaching your kidneys and bones, which is why Descovy tends to cause fewer side effects in those areas. In the large DISCOVER trial comparing the two drugs head-to-head for PrEP, Descovy matched Truvada’s effectiveness at both 48 and 96 weeks of follow-up.
Timeline for HIV Treatment
If you’re taking Descovy as part of a combination regimen to treat HIV (not prevent it), the timeline looks different. You won’t feel the drug “working” in any noticeable way, but lab tests will show your viral load dropping. Most people on antiretroviral therapy reach an undetectable viral load within 8 to 24 weeks. The exact timing depends on how high your viral load was before starting treatment and which other medications are in your regimen.
Undetectable means the amount of virus in your blood falls below what lab tests can measure. This is the goal of treatment, and reaching it means the virus can no longer damage your immune system or be transmitted to sexual partners. Your care team will monitor your viral load regularly to confirm you’re on track.
What Happens If You Miss a Dose
Descovy’s protection is tightly linked to consistent daily dosing. People who miss doses have a measurably higher risk of acquiring HIV than those who take it every day. This held true in clinical trials for both Descovy and Truvada.
There’s no established “grace period” for missed doses. Some pharmacokinetic data suggest the drug lingers in cells for a while after you stop taking it, but no clinical study has confirmed how long protection actually lasts after a missed dose. The safest approach is to take Descovy at roughly the same time each day and treat it as non-negotiable. If you miss a dose, take it as soon as you remember and continue your regular schedule.
Testing Before and During Use
You can’t simply start Descovy and assume you’re covered. A confirmed negative HIV test is required before beginning PrEP, because taking Descovy while unknowingly HIV-positive could lead to drug resistance. Your provider will also screen for sexually transmitted infections like chlamydia, gonorrhea, and syphilis, check your kidney function, test for hepatitis B, and assess your cholesterol and triglyceride levels.
Once you’re on Descovy, expect follow-up visits at least every three months. Each visit includes HIV testing and an STI screen if you have symptoms or risk factors. Kidney function gets checked every 6 to 12 months depending on your age and baseline results. Cholesterol and triglycerides are reassessed annually. These visits aren’t optional extras. They’re how your provider confirms the drug is still safe for you and that you haven’t acquired HIV between appointments.
Putting the Timeline Together
For PrEP through receptive anal sex, plan on 7 days of daily dosing before relying on Descovy for protection. For HIV treatment, expect 8 to 24 weeks before reaching an undetectable viral load. In both cases, the drug only works as well as your adherence. Skipping doses erodes the intracellular drug levels that make Descovy effective, and there’s no proven shortcut to rebuild them faster than resuming daily use.